Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment

Journal of Psychopharmacology

Volumn 24, Issue 12, 2010, Pages 1810-1818

  Gürkan, Kaǧan ^a   Bilgiç, Ayhan ^b   Türkoǧlu, Serhat ^b   Kiliç, Birim G ^a   Aysev, Ayla ^a   Uslu, Runa ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

anxiety; attention deficit hyperactivity disorder (ADHD); children; depression; health related quality of life; methylphenidate; obsessive compulsive symptoms

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCHOOL CHILD; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADOLESCENT; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; METHYLPHENIDATE; OBSESSIVE-COMPULSIVE DISORDER; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 78650156202     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109348172     Document Type: Article

References (48)

1. American Psychiatric Association (APA) (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
2. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. (1990) Side effects of MPH in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Paediatrics 86: 184-192.
3. Biederman J., Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 16-22: 237-248.
4. Borcherding BG, Keysor CS, Rapoport JL, Elia J., Amass J. (1990) Motor/vocal tics and compulsive behaviours on stimulant drugs: is there a common vulnerability ? Psychiat Res 33: 83-94.
5. Buhagiar K., Cassar J. (2007) Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature. Turk Psikiyatri Derg 18: 179-183.
6. Çakin Memik N., Aǧaoglu B., Coşkun A., Karakaya I. (2008) The validity and reliability of Paediatric Quality of Life Inventory in 8-12 years old Turkish children. Çocuk ve Gençlik Ruh Saǧliǧi Dergisi 15: 87-98.
7. Çakin Memik N., Aǧaoǧlu B., Coşkun A., Üneri OS, Karakaya I. (2007) The validity and reliability of the Turkish Paediatric Quality of Life Inventory for children 13-18 years old. Turk Psikiyatri Derg 18: 353-363.
8. Cantwell DP (1996) Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adol Psy 35: 978-987.
9. Conners CK, Sitarenios G., Parker JD, Epstein JN (1998 a) The revised Conners' Parent Rating Scale (CPRS-R). factor structure, reliability, and criterion validity. J Abnorm Child Psych 26: 257-268. (Pubitemid 28359774)
10. Conners CK, Sitarenios G., Parker JD, Epstein JN (1998 b) Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R). factor structure, reliability, and criterion validity. J Abnorm Child Psych 26: 279-291.
11. Diamond IR, Tannock R., Schachar RJ (1999) Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adol Psy 38: 402-409.
12. DuPaul GJ, Barkley RA, McMurray MB (1994) Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adol Psy 33: 894-903.
13. Erol N., Savaşir I. (1988) Maudsley Obsesif Kompulsif Soru Listesi. 24. Ulusal Psikiyatri ve Nrolojik Bilimler Kongresi Bilimsel alma Kitab. 107-114, GATA, Ankara.
14. Fernandez F., Levy JK, Samley HR, et al. (1995) Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine. Int J Psychiat Med 25: 53-67.
15. Flapper BC, Schoemaker MM (2008) Effects of methylpenidate on quality of life in children with both developmental coordination disorder and ADHD. Dev Med Child Neurol 50: 294-299.
16. Gillberg C., Gillberg IC, Rasmussen P., et al. (2004) Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adoles Psy 13: 180-92.
17. Goez H., Back-Bennet O., Zelnik N. (2007) Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder. J Child Neurol 22: 538-542.
18. Gokler B., Unal F., Pehlivanturk B., Cengel Kultur E., Devrim Akdemir D., Taner Y. (2004) Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version - Turkish version (K-SADS-PL-T). The Turk J Child Adol Mental Healt 11: 109-116 (in Turkish).
19. Greenhill LL, Pliszka S., Dulcan MK, et al. (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adol Psy 41: 26S - 49S.
20. Gwirtsman HE, Szuba MP, Toren L., Feist M. (1994) The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate. Psychopharmacol Bull 30: 157-164.
21. Hakkaart-van Roijen L., Zwirs BW, Bouwmans C., et al. (2007) Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adoles Psy 16: 316-326.
22. Hodgson RJ, Rachman S. (1977) Obsessional-compulsive complaints. Behav Res Ther 15: 389-395.
23. Joffe RT, Swinson RP (1987) Methylphenidate in primary obsessive- compulsive disorder. J Clin Psychopharmacol 7: 420-422.
24. Joffe RT, Swinson RP, Levitt AJ (1991) Acute psychostimulant challenge in primary obsessive compulsive disorder. J Clin Psychopharmacol 11: 237-241.
25. Kaner S., Büyüköztürk Ş., Şeri E., Ak A., Özaydin L. (2006 a) The validity and reliability study of the Turkish version of Conners' Parent Rating Scale- Revised (CPRS-R). In: 16th National Child and Adolescent Psychiatry Congress, 20-23 Nisan 2006, Antalya, Abstract book, 69.
26. Kaner S., Büyüköztürk Ş., Seri E., Ak A., Özaydin L. (2006 b) The validity and reliability study of the Turkish version of Conners' Teacher Rating Scale- Revised (CTRS-R). World Psychiatric Association Congress, July 12-16, Istanbul. Turk Psikiyatri Derg, 17: 227.
27. Kaufman J., Birmaher B., Brent D., et al. (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL). initial reliability and validity data. J Am Acad Child Adol Psy 36: 980-988.
28. Klassen AF, Miller A., Fine S. (2004) Health related quality of life in children and adolescents who have a diagnosis of attentiondeficit/hyperactivity disorder. Paediatrics 114: e541 - e547.
29. Klassen AF, Miller A., Fine S. (2006) Agreement between parent and child report of quality of life in children with attention-deficit/ hyperactivity disorder. Child: Care, Hlth Dev 32: 397-406.
30. Kotsopoulos S., Spivak M. (2001) Obsessive-compulsive symptoms secondary to methylphenidate treatment. Can J Psychiat Revue Canadienne de Psychiatrie 46: 89.
31. Kouris S. (1998) Methylphenidate induced obsessive compulsiveness. J Am Acad Child Adol Psy 37: 135.
32. Kovacs M. (1985) The Children's Depression Inventory (CDI). Psychopharmacol Bull 21: 995-998.
33. Lee H., Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS (2005) Comparing effects of methylphenidate, sertarline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol 20: 97-104.
34. Öy B. (1991) Children's Depression Inventory: a study of reliability and validity. Turk J Psychiat 2: 132-136 (In Turkish).
35. Özusta Ş. (1995) Turkish standardization, reliability and validity of State Trait Anxiety Inventory for children. Turk J Psychiat 10: 32-44 (In Turkish).
36. Pliszka SR (1992) Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. J Am Acad Child Adol Psy 31: 197-203.
37. Reimherr FW, Williams ED, Strong RE, Mestas R., Soni P., Marchant BK (2007) A double-blind, placebo controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiat 68: 93-101.
38. Rickels K., Gingrich Jr RL, McLaughlin FW, et al. (1972) Methylphenidate in mildly depressed outpatients. Clin Pharmacol Ther 13: 595-601.
39. Rösler M., Fischer R., Ammer R., Ose C., Retz W. (2009) A randomized, placebo controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/ hyperactivity disorder. Eur Arch Psychiat Clin Neurosci 259: 120-129.
40. Savaşir I., Şahin N. (1995) Wechsler Çocuklar Için Zeka Ölçeǧi (WISC-R) el Kitabi. Ankara: Türk Psikologlar Derneǧi Yayinlari (in Turkish).
41. Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR, Jacobs GA (1983) Manual for the State-trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
42. Swanson J., Kinsbourne M., Roberts W., Zucker K. (1978) Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Paediatrics 61: 21-29.
43. The MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/ hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiat 56: 1073-1086.
44. Tannock R., Ickowicz A., Schachar R. (1995) Differential effects of MPH on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adol Psy 34: 886-896.
45. Varni JW, Seid M., Rode AC (1999) The PedsQL: the measurement model for the Paediatric Quality of Life Inventory. Med Care 37: 126-139.
46. Wechsler D. (1974) WISC-R Manual for the Wechsler Intelligence Scale for Children - Revised. New York: Psychological Corporation.
47. Weiss M., Weiss G. (2002) Attention deficit hyperactivity disorder, In: Lewis M, (ed.) Child and Adolescent Psychiatry, a Comprehensive Textbook. Philadelphia, PA: Lippincott Williams&Wilkins.
48. Yang P., Hsu HY, Chiou SS, Chao MC (2007) Health related quality of life in methylphenidate-treated children with attention-deficit/ hyperactivity disorder: results from a Taiwanese sample. Aust NZ J Psychiat 41: 998-1004.